LPAR3 and hepatocellular carcinoma: Another article indicated that LPAR3 conferred chemo-resistance by upregulating multidrug resistance-related genes because the cell survival in LPAR3-expressing rat hepatoma cells treated with cisplatin or doxorubicin was higher than controls [20].